BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xie Y, Jiang Y, Yang XB, Wang AQ, Zheng YC, Wan XS, Sang XT, Wang K, Zhang DD, Xu JJ, Li FG, Zhao HT. Response of BRCA1-mutated gallbladder cancer to olaparib: A case report. World J Gastroenterol 2016; 22(46): 10254-10259 [PMID: 28028375 DOI: 10.3748/wjg.v22.i46.10254]
URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10254.htm
Number Citing Articles
1
Bhausaheb Bagal, Rohit Kumar, Tarang Gaur, Vikas Talreja, Avinash Bonda, Nikhil Patkar, Dhanlaxmi Shetty, Pradnya Kowtal, P. G. Subramanian, Sudeep Gupta, Rajiv Sarin, Syed K. Hasan. Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapyMedical Oncology 2020; 37(5) doi: 10.1007/s12032-020-01371-z
2
Ryosuke Okamura, Razelle Kurzrock, Robert J. Mallory, Paul T. Fanta, Adam M. Burgoyne, Bryan M. Clary, Shumei Kato, Jason K. Sicklick. Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancersInternational Journal of Cancer 2021; 148(3): 702 doi: 10.1002/ijc.33230
3
Xiaofen Li, Limin Gao, Meng Qiu, Dan Cao. Olaparib Treatment in a Patient with Advanced Gallbladder Cancer Harboring BRCA1 MutationOncoTargets and Therapy 2021; : 2815 doi: 10.2147/OTT.S303594
4
Mao Li, Yu Mou, Shengzhong Hou, Dan Cao, Ang Li. Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparibMedicine 2018; 97(45): e13113 doi: 10.1097/MD.0000000000013113
5
Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, Nastassja Tober, Andrea Palloni, Veronica Mollica, Ilaria Maggio, Marzia Deserti, Simona Tavolari, Giovanni Brandi. PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?Medicines 2020; 7(9): 54 doi: 10.3390/medicines7090054
6
James M. Bogenberger, Thomas T. DeLeon, Mansi Arora, Daniel H. Ahn, Mitesh J. Borad. Emerging role of precision medicine in biliary tract cancersnpj Precision Oncology 2018; 2(1) doi: 10.1038/s41698-018-0064-z
7
Vladimir Bezrookove, John M. Patino, Mehdi Nosrati, Pierre-Yves Desprez, Sean McAllister, Liliana Soroceanu, Ari Baron, Robert Osorio, Mohammed Kashani-Sabet, Altaf A. Dar. Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication StressCancers 2021; 13(17): 4405 doi: 10.3390/cancers13174405
8
Ahmad Al-Taee, Ammara Gill, Suzanne Mahon, Jinping Lai, Bassel Jallad. Gallbladder Adenocarcinoma as the First Manifestation of Germline BRCA1 MutationJournal of Gastrointestinal Cancer 2019; 50(1): 147 doi: 10.1007/s12029-017-9995-9
9
Jorge Adeva, Bruno Sangro, Maximiliano Salati, Julien Edeline, Adelaida La Casta, Alessandro Bittoni, Rossana Berardi, Jordi Bruix, Juan W Valle. Medical treatment for cholangiocarcinomaLiver International 2019; 39(S1): 123 doi: 10.1111/liv.14100
10
Rutika Mehta, Anthony C Wood, James Yu, Richard Kim. Investigational PARP inhibitors for the treatment of biliary tract cancer: spotlight on preclinical and clinical studiesExpert Opinion on Investigational Drugs 2021; 30(4): 451 doi: 10.1080/13543784.2021.1898586